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Abstract    
 
This paper concentrates on controversies about children’s consent, and 
reviews how children’s changing status as competent decision makers about 
healthcare and research has gradually gained greater respect. Criteria for 
competence have moved from age towards individual children’s experience 
and understanding. Uncertain and shifting concepts of competence and its 
identification with adulthood and childhood are examined, together with levels 
of decision-making and models for assessing children’s competence. Risks 
and uncertainties, methods of calculating the frequency and severity of risks, 
the concept of ‘therapeutic research’ and problems of expanding consent 
beyond its remit are considered. The paper ends by considering how 
strengths and limitations in children’s status and capacities to consent can be 
mirrored in researchers’ and practitioners’ own status and capacities. 
Examples are drawn from empirical research studies about decision-making 
in healthcare and research involving children.  
 
 
 
 2 
Introduction    
 
This paper relates consent to children’s bodies, health and illness, their views 
and behaviours, (dis)abilities and experiences, their rights, relationships and 
status. The paper mainly considers current English/Commonwealth law and 
guidance, but also refers to some international influences and to historical 
examples that are basic to, or have developed towards, present policy. 
Guidance in law and ethics on healthcare and research has variously either 
ignored children (Nuremberg, 1947) or intensely discussed them (US, 1997; 
RCPCH, 2000; BMA, 2001; MRC, 2004), carefully protected them or entered 
them into high risk research (Beecher, 1966; Pappworth, 1967; Sharav, 
2003), regarded them as either the last (RCPCH, 2000) or as the first 
(Nuffield, 1992) group to take part in research. This paper concentrates on 
controversies about children’s consent. It reviews children’s status and rights 
to consent, various definitions and assessments of their competence, and 
calculations of risk. Consent to healthcare treatment and consent to research 
often overlap when research investigates treatment, and the concept of 
‘therapeutic research’ and the limited remit of consent are critically analysed. 
Finally, children’s status and capacities to consent are reviewed as possibly a 
reflection, mirror image, or indicator of practitioners’ and researchers’ own 
status and capacities.    
 
 
Children’s status in decision-making: guidance in law and ethics  
 
Beyond an age of consent: the law 
There is a movement beyond an arbitrary ‘age of consent’ towards respect for 
individual children’s abilities. This is partly because, as will be illustrated in later 
sections, contingencies such as experience and ability can be more salient than 
age to a child’s competence. The statutory age of consent to treatment varies 
considerably between countries from 12 to 19 years, illustrating how arbitrary it 
can be. However, formerly the child's status, as silent infant or articulate young 
adult, has been keenly debated around questions of an age of consent to 
health treatment and research. Anglo-American law recognises that `Every 
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human being of adult years and sound mind has the right to determine what 
shall be done with his own body' (my emphasis) (Cardozo, 1914). Until recently, 
obedience rather than autonomy has been expected of children. 
  The emphasis is changing around the world in British Commonwealth 
countries influenced by English law, from attention to a stated age of consent to 
interest in individual ability (Gillick, [1985] 3 All ER 423). The Gillick ruling does 
not specify an age when children become competent, but defines a competent 
child as one who `achieves a sufficient understanding and intelligence to 
enable him or her to understand fully what is proposed', and has `sufficient 
discretion to enable him or her to make a wise choice in his or her own 
interests'. The parental right to consent `terminates’ when the child achieves 
this competence (Ibid). `Nor has our law ever treated the child as other than a 
person with capacities and rights recognised by law (Gillick, [1985], 2 WLR 
480)'. Parents have a `dwindling right which the courts will hesitate to enforce 
against the wishes of the child. It starts with a right of control and ends with little 
more than advice' (Hewer v. Bryant  [1970] 1 QB 357, 369). In the US, doctors 
have long been permitted to treat ‘mature minors’: young people who have left 
home or who have drug, alcohol or sexual problems and who want to be 
treated without their parents’ knowledge and consent (Gaylin and Macklin, 
1982). During the 1970s and 1980s, some judges in Britain did recognise 
minors’ rights and capacities. However, in the 1990s a few court cases 
contracted the Gillick ruling by refusing to recognise certain minors as 
competent, for example, (Re J [1991]; Re W [1992]). Although these cases 
involved mental health problems, and the rulings therefore have limited 
relevance to most young people, they have been widely influential.  
  For years, the government has advised that `young people should be kept as 
fully informed as possible about their condition and treatment to enable them to 
exercise their rights' (DH, 1991), and that their wishes (Children Act, 1989, s 8) 
and views (UNCRC, 1989, article 12) should be heard. There should be respect 
for `informed, free, express and specific consent' (DH, 1991). The government 
now advises professionals to encourage young people aged from about 12 
years to involve their parents in deciding about their care and treatment, but not 
to enforce this, and to accept the consent of young people who do not want 
their parents to be informed and involved (ECM, 2006). In Britain, doctors are 
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protected against prosecution when they treat children aged under 16 years 
without parental consent if they claim that in their clinical judgement the child is 
competent to consent (Age of Legal Capacity (Scotland) Act, s 2 (4) 1991).   
  Legal debates about minors’ consent have complex contexts. The debates 
are less concerned with children’s rights than with adults’ freedoms. These 
include lawyers’ concerns to safeguard human autonomy and privacy rights, 
and judges’ and parents’ powers to decide for children (Bynoe, 1993:7). There 
are also governments’ and doctors’ anxieties that if judges rule that parents 
must always be involved in decisions about minors, including decisions about 
contraception and abortion, many young people will be unable to trust medical 
services to respect their privacy and will avoid using them. Rates of sexually 
transmitted disease and unwanted pregnancies are therefore likely to rise 
rapidly. So legal rulings such as Gillick, and government guidance (ECM, 
2006), which appear to respect young people’s decision-making rights, may 
be more influenced by motives to protect them and assure they can receive 
treatment and advice.  
  Inquiries into scandals about medical maltreatment of living and deceased 
babies and children in English hospitals (Kenney, 2001; Redfern, 2001) 
indicate particular public concern with consent as a means to protect children, 
both living and dead. Kennedy’s inquiry report (2001) advised that consent 
should precede every clinical intervention and all ‘touching’. (Technically, 
illegal ‘assault’ means unwanted touching, not necessarily violence.) The 
inquiries have led to a renewed and stronger emphasis in English guidance 
and law on consent, for example, NSF (2004), Human Tissue Act (2004). 
Shenoy et al. (2003:17) concluded that such emphases would require ‘drastic 
changes’ to clinical practice.  
  To summarise the present position on health care treatment: in English law, 
the people who can give valid consent to medical treatment for a child include 
the competent child and anyone who has parental responsibility for the child 
under the 1989 Children Act. Following re R ([1991] 4 All 177), the consent of 
only one of these people (child or parent) to treatment can overrule the refusal 
of all the others. Therefore treatment may be enforced on a resisting child if it 
is considered to be in the child’s best interests.  
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Consent to research 
 
This section reviews current guidance and also earlier sources on which 
present standards are based or from which they developed. Modern 
international bioethics guidance on research began with the Nuremberg Code 
(1947:1), which opens with what may still be the best definition of consent.   
 
‘1. The voluntary consent of the human subject is absolutely essential. This 
means that the person involved should have legal capacity to give consent; 
should be so situated as to be able to exercise free power of choice, without the 
intervention of any element of force, fraud, deceit, duress, overreaching, or 
ulterior form of constraint or coercion.’ 
 
Nuremberg does not mention ‘informed consent’ but assumes that, when 
properly informed, ordinary people can make ‘enlightened decisions’ about 
whether to consent to research. Nuremberg dealt only with research on healthy 
adults and vetoed research on children, who were assumed to lack legal 
capacity. The loophole that Nuremberg left in not covering ‘therapeutic’ 
research involving medical treatment is shown by British guidance (MRC, 1964: 
21-5), which was not revised until 1991. It stated that if the doctor researching a 
treatment is satisfied that the treatment will benefit the patient, because of the 
‘willingness on the part of the subject to be guided by the judgement of the 
medical attendant he [the doctor] may assume the patient's consent [as he 
would assume consent to] established practice’ – without the person’s 
knowledge or consent. 
  By 1964, Nuremberg’s legal concern with the human rights of ‘healthy 
volunteers’ was superseded by the medically authored Declaration of Helsinki 
(WMA, 1964/2000). Nuremberg can be regarded as a response to unjustifiably 
harmful research in concentration camps during World War II. In contrast, 
Helsinki addresses the dangers of under-researched treatments. It was first 
published after thalidomide was reported in 1963 to have caused many fetal 
limb malformations when women took the medication during pregnancy, and is 
another example of dangers to babies and children, which have alerted public 
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attention and led to new ethics guidance. Helsinki affirmed the benefits of 
research and faith in physicians who are dedicated `to help suffering humanity' 
and who alone are fully qualified to make accurate risk-benefit assessments. 
The research subjects' `freely given informed consent' is not mentioned until 
clause 9, and `responsibility for the human subject must always rest with the 
medically qualified person and never rest on the subject'. Physicians are trusted 
to research on children with parental consent (clause 11) and, by the 1983 
version of Helsinki, the competent  ‘minor's consent must be obtained in 
addition to the consent of the minor's legal guardian.'    
  In the United States, there is a long tradition that the consent of 
parents/guardians to research must be sought `at all ages of the child; 
furthermore the child's assent should be sought from the age of 7 upwards' (US 
1977). ‘Assent’ here is non-refusal or simple agreement without the 
understanding, discretion and legal validity associated with consent, and the 
term does not appear to be used much in English law. For example, it is 
missing from Montgomery (1997) and Kennedy (1988). This may be because 
English law recognises minors’ consent, but United States (US) law does not, 
and assent allows a partial recognition. However, the thorough multi-
disciplinary guidance on research developed in the US (1977) influenced 
English guidance (BPA, 1980; Nicholson, 1986; MRC, 1991; RCPCH, 1992). 
Children have fewer rights in the US when research investigates treatment. `On 
a cautious view of the law' with `therapeutic research', the parents' consent can 
`be deemed to override the refusal of assent by the child aged under 14 
[although] non-therapeutic research should not be carried out if a potential child 
subject aged 7 to 14 years refuses assent to it' (US, 1977). 
  Similarly, in English guidance, the child has a higher status in decision-
making as a potential research participant than as a patient. Adults must take 
extremely seriously the refusal or resistance of even very young children to 
research, which is not associated with treatment (RCPCH, 1992/2000; BMA, 
2001:234), and `the investigator should reconsider whether it would be 
appropriate to proceed' (RCP, 1990a) as well as working to enhance and 
encourage children’s share in decision-making (BMA, 2001:232). `Either those 
included have given consent, or consent has been given on their behalf by a 
parent or guardian and those included do not object or appear to object in 
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either words or action…When a child lacks sufficient understanding to consent, 
his willing cooperation should be sought' (MRC, 1991, and similarly MRC, 
2004). Children should be consulted and informed in terms they can 
understand (BMA, 2001). ‘When parental consent is obtained, the agreement of 
school age children to take part in research should also be requested by 
researchers’ (RCPCH, 2000/1992).  `Research which could equally well be 
done on adults should never be done on children' (RCP, 1990b; CMCE, 1990). 
In the absence of English statute or case law on consent to research, the 
guidance has cautioned that: ‘it would be unacceptable not to have the consent 
of the parents or guardian', for children aged up to 18 years even when they are 
deemed competent to consent, to any intervention which is not for the benefit of 
the child especially if it carries more than ‘negligible risk’, `it could be said they 
were acting illegally' (RCP, 1990a). Growing concern that most clinical 
interventions on children are under-researched and under-tested (ABPI, 2004) 
has led to international efforts to expand and regulate neonatal and paediatric 
research. As a result, insistence on involving parents’ consent during all clinical 
trials on minors passed into law in 2004, when the government implemented 
the EC Directive (EC, 2001). But the law applies only to clinical trials. There is 
not space here to review the varying guidance on children’s consent that has 
been agreed by many disciplines and agencies, which conduct psychological 
and social healthcare research with children (see Alderson and Morrow, 2004).   
 
 
Children’s rights 
 
The 1989 United Nations Convention on The Rights of the Child (UNCRC, 
1989) has been ratified by every country except the US and Somalia. 
Conventions are the most powerful treaties and the UNCRC has far more 
support than any other treaty. Governments undertake to implement the 
Convention in law, policy and practice and to report regularly to the UN about 
their progress in doing so. The UNCRC’s 54 articles promote children’s 
‘provision’ rights to services and amenities, their rights to ‘protection’ from 
abuse or neglect, and their ‘participation’ or modified autonomy rights. Like all 
rights, these are subject to public safety, health, law, order and morals. 
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UNCRC rights further respect children’s best interests and parents’ 
responsibilities. Particularly relevant to consent, Articles 12 and 13 state that 
governments must assure:  
 
‘To the child who is capable of forming his or her own views the right to 
express those views freely in all matters affecting the child: the views of the 
child being given due weight in accordance with the age and maturity of the 
child…The child shall in particular be provided the opportunity to be heard in 
any judicial or administrative proceedings affecting the child, either directly, or 
through a representative or appropriate body. [There are also rights] to 
freedom of expression… freedom to seek, receive and impart information and 
ideas of all kinds…through any other media of the child’s choice.’ 
  
Many practitioners and researchers create imaginative leaflets, toys and 
videos to inform young children about proposed interventions. Nuremberg and 
Helsinki and their history illustrate the importance of respecting the status of 
potential research participants, informing and listening to them, and working 
as far as possible in partnership with them. The UNCRC emphasises these 
approaches particularly with children. However, the level of shared 
involvement partly depends on perceptions of the child’s competence, as 
reviewed in the next sections.   
 
 
Concepts of competence 
 
Adult research subjects are assumed to be competent unless they obviously 
show serious incompetence. Researchers tend to start from a presumption of 
incompetence with children, a double disadvantage for children since it is hard 
for them to challenge the strong views of the relatively more powerful and 
confident adults, and it is harder to demonstrate competence than 
incompetence, which can fairly easily seem to be proved by one or two 
mistakes or misunderstandings. The following sections review debates about 
children’s competence. 
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‘Children cannot give consent’ 
 
This is the accepted view in the US (for example, NIH, 2007). Yet although, in 
many countries, children cannot give legally valid consent, it does not follow 
that they are intellectually and morally incompetent, despite enduring beliefs 
about their limited reasoning and morality. Piaget’s experiments during the 
1920s and 1930s (Piaget & Inhelder, 1956) found that children aged under 7 
years could not imagine, or reason from, the perspective of a model of 
mountains that would be seen by someone standing in another position from 
their own. Leaping from geometry to morality, Piaget inferred that children 
were therefore egocentric and unable to distinguish themselves from others. 
However, his conclusions were challenged when researchers reframed his 
experiment into a story of boys hiding from one and then two policemen. They 
found that some children aged 3 years could solve harder geometric puzzles 
(Donaldson, 1978) and that, far from being unaware of others’ viewpoints, the 
children were so highly aware that they tried to please by giving the replies 
they thought the researchers wanted to hear. ‘Children are not at any stage as 
egocentric as Piaget has claimed [or] so limited in ability to reason 
deductively…At least from age four, then, we must again acknowledge that 
the supposed gap between children and adults is less than many people have 
claimed’ (Donaldson, 1978: 58-9). Ironically, Piaget appeared less able to 
perceive the children’s viewpoints than they could perceive his.  
  Interpersonal relationships appear to be very important to all children. 
Although the youngest children cannot make decisions, even babies are 
already on the human spectrum of awareness, beginning to discriminate, 
distinguish and to invest meanings in experiences, interactions and other 
people’s moods and behaviours (Murray & Andrews, 2000:). By 6 months, 
babies show surprise when effect seems to follow cause (Siegal, 1997). And 
yet bioethicists (for example, Miller, 2004; Grodin & Glantz, 1994) continue to 
ignore decades of research about young children’s competence. Echoing 
Piaget’s mountain experiment, Buchanan and Brock (1989:220) assert, for 
example, that younger children cannot appreciate different personal positions. 
‘These skills are undergoing substantial development in the 8 to 11 age 
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period, and are often quite well developed by 12 to 14’. Children’s slow 
physical development is taken to signify equally slow psychological, emotional 
and moral growth, and highly informed young children are dismissed as 
`precocious’ or ‘outliers’.      
  Childhood and youth tend to be associated with being ignorant, volatile, 
foolish, over-emotional, needy and helplessly dependent. Conversely, 
adulthood tends to be identified with being informed, stable, wise, rational, 
reliable and above all competent. However, at times many children can be 
wise and many adults can be foolish. The characteristics are more realistically 
understood as combined at every age instead of being age-associated. The 
newer childhood studies research is producing evidence of higher 
competencies even in young children (Hutchby & Moran Ellis, 1998), through 
listening to children’s own views and explanations, and through in-depth 
research with sick or disabled children about their everyday lives and real 
decision-making. Adversity may increase knowledge, skills and courage when 
children cope with disability or illness in ways that more fortunate people may 
not imagine (Alderson, 1990, 1993). For example, 6 year old Samantha was 
willing to go through two liver transplants, but after they failed she wanted to 
refuse a third one. Reluctantly, her parents and doctors came to believe that 
her decision was right for her, given the suffering involved and the estimated 
two per cent chance of success (Irwin, 1996).     
  Children who have long-term conditions know far more than people who 
have acute or emergency conditions. Children as young as 2 years have been 
shown to know the names and purpose of their cancer drugs (Kendrick, et al., 
1986), and children in cancer wards have deliberately protected their parents 
by not telling them how much they, the children, knew or suffered (Bluebond 
Langner, 1978). I interviewed 120 people aged 8 to 16 years having elective 
major surgery, and also their parents and 70 hospital staff, and asked them all 
the age when the children were or would become as competent as their 
parents to `be the main decider’. On average the young people had already 
had four to five operations, and they had one or more serious long-term 
conditions. Linda (pseudonym), aged 8 years, who had spina bifida, 
hydrocephalus and kyphosis (curved spine), was waiting for her fifth 
operation. Her mother explained:  
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‘I usually tell her everything. She wants to know exactly what is entailed. Last 
year her urethra ruptured and she was very upset that she wasn’t warned fully 
about the catheters…She’s maturing very quickly and she asks, “Why me? 
Why is my body made wrong?” [The surgeon] said, “Ten percent of these 
children don’t come out of the theatre alive.” …She reads books a lot, she 
writes down her questions and asks them in the clinic, but I haven’t told her 
about that [mortality] risk (Alderson, 1993: 127-8).  
 
Interviewed with her mother and aunt, Linda was cheerful: ‘We’ve been 
waiting for ages. I say, thank goodness I’m getting it over and done with.’ I 
asked her whom the doctors should talk to. ‘Mummy and me. And auntie 
should hear too, so she doesn’t get worried. (She leant over to kiss her aunt.) 
But particularly me, so I can face up to it if I’m frightened.’ After the adults left, 
Linda hinted to me about her controlled anxiety. ‘When I get back tomorrow 
[after surgery] they’ll be in tears for me.’ Earlier her mother had told me that 
Linda asked why the neighbours were crying when she had said goodbye to 
them. Only a few examples of ’ordinary’ young children are required to refute 
generalisations about their supposed incompetence. When they demonstrate 
understanding of their serious condition and potential treatment choices, it is 
no longer viable to speak of general incapacity below the age of 7, 10 or 14 
years as many commentators still do.  
  In Britain, around 18% of people aged under 20 have a long term condition 
(NSO, 2007), and many have to ‘consent’ to years or a life time of a 
prescribed treatment regime – a strict diet, daily injections, medicines or 
physiotherapy. Although less dramatic and risky than consent to surgery, 
children’s cooperation with the regime has to involve an informed commitment 
well beyond passive compliance. Their health is often in their own hands. 
Everyday evidence of children aged 3 and 4 years, with such conditions as 
cystic fibrosis or type 1 diabetes, shows how responsible they can be when 
adults are not present. For example, children with diabetes refuse sweets, 
which their friends enjoy, and cope in sophisticated ways with being different 
yet sustaining friendships (Alderson, et al., 2006). Unless they understand the 
reasons for painful or frustrating treatment children could be overwhelmed 
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with fear or anger. By age 4 or 5 years, children have mapped out their life-
long understandings of self, others and relationships, time and space, art and 
much basic science (Gardner, 1991). These sense-making abilities suggest 
that, even if their consent is not requested, informing them as much as 
possible about the nature, purpose and likely effects of interventions can 
reduce fearful misunderstandings.   
 
 
Levels of decision-making  
 
There are four levels in decision-making (Alderson & Montgomery, 1996:66): 
to be informed; to express an informed view; to have that view taken into 
account when decisions are made; to be the main decision maker about 
proposed interventions, if competent to do so and potentially subject to 
supervision of the courts. The highest level includes signifying the decision 
and taking responsibility whatever the outcome. It is often argued that children 
cannot and should not make major decisions, for reasons linked to the four 
levels listed above: they cannot understand the relevant information; they 
cannot evaluate information in the light of lasting personal values; they cannot 
know their own best interests, so that adults must act for them; and, if things 
go wrong, children do not yet have the courage and resolve to stand by a 
decision, and will need to blame other people instead of enduring risk, guilt 
and blame themselves. Doctors used all these arguments in the past to 
protect adult patients from complex and distressing information and decision-
making.  
  Yet efforts to protect children from having to decide about healthcare 
research and treatment may protect adult power as much as children’s 
interests. During the study about children’s consent to surgery, a hospital 
chaplain said he believed that children’s competence greatly depends on 
adults’ competence to be supportive, generous, courageous and `big enough’ 
to respect children.  
 
‘But are you going to lay on children the weight of their future? Perhaps let 
them make a decision that could lead to their death? These are impossible 
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questions, but hospital staff have to find the answers. Am I big enough to say, 
“Whatever you choose will be valued, even if you decide against the tide; 
okay, you've made that decision, I'll do all I can to support you, and we'll go 
forward together”? It's such a big step for the adult to surrender power to the 
child’ (Alderson, 1993:143).  
   
  The UNCRC (1989) articles 12 and 13 recognise the first three levels of 
children’s involvement in decision-making, of sharing information, without any 
age barrier. Relevant information may be acquired from children’s own 
embodied feelings and experiences, such as when healthy babies set the 
timing and pace of feeds that establish breastfeeding. Immensely detailed 
observations of premature babies find how subtly they express their needs in 
a ‘language’ that can be ‘read’ (Als, 1999:34). Their need for quiet, for dim 
lighting and reassuring touching and talking are used to transform some 
neonatal unit-wide routines (Alderson, et al., 2005, 2006).   
  The fourth and highest level of decision-making is to be the ‘main decider’ 
about proposed treatment, if the child is both able and willing to do so. 
Although not covered in the UNCRC, this is enshrined in English law (Gillick, 
[1985]) and recommended practice (RCPCH, 2000; BMA, 2001:232). Replies 
to my research about the age of competence to consent to surgery (see 
above, Alderson, 1993:143-74), ranged from one surgeon saying `never’ to 
some adults and children stating ages from 6 years upwards. Much depended 
on the child, the family, the condition and the beliefs of each interviewee. Most 
of the children wanted to share the decision-making with their doctors and 
parents. A minority (not age-related) either wanted others to decide for them 
or else to be `the main decider’ about proposed surgery. Nurses said that 
after years of working with children they respected them at younger ages. The 
children’s understanding appeared to depend far more on their experience 
than their age or ability. 
 
 
Assessing competence 
 
Four standards of mental competence are commonly assessed in the person 
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giving consent. Are they sufficiently able to: understand the relevant 
information; retain the information; weigh the information in order to make a 
reasoned choice; and make voluntary and autonomous decisions? Two other 
standards are the ability to communicate the decision, and the ability ‘to 
believe the information’ (Mental Capacity Act, 2005).‘Belief’ here means not 
being deluded, but it could be misconstrued to assess as incompetent anyone 
who disbelieves/disagrees with the doctors’ information and wants to refuse 
interventions they consider to be unnecessary or even harmful. If so, that 
would deny any rational grounds for refusal. Yet in the US there are many 
reports, for example, of parents wanting but being unable to stop enforced 
administration of Ritalin to treat children’s perceived conduct disorders 
(Baughman, 2006).  
  It is also important to assess the competencies of the practitioners/ 
researchers who are requesting consent. Are they sufficiently able: to 
understand all the relevant information; to retain and explain all the issues 
clearly and resolve misunderstandings; to assist children and parents in their 
reasoned choice-making; and to respect their decisions, putting no undue 
pressures on them? Much depends on the training and skills of practitioners 
and researchers, on their understanding of how childhood incompetencies are 
socially constructed (James and Prout, 1997), and also on the support or 
opposition they receive from colleagues when they risk advocating children’s 
views and preferences.    
  Assessors can rely on three models of competence (US, 1977; Brazier, 
1992). Status: is the person a competent adult or a non-competent 
baby/young child/ elderly demented person? Outcome: does the assessor 
consider the person’s decision is reasonable? Function: even if the assessor 
disagrees with the decision does the reasoning that explains and justifies it 
seem to be valid? The first two views tend to favour the assessors’ prior fixed 
assumptions, whereas the third approach is most likely to involve respectful 
flexible consideration of the individual’s competence and decisions through 
negotiation. Then the practitioner’s/researcher’s information can complement 
the patient’s personal knowledge and values so that together they can make 
more informed decisions with mutual respect. Linda’s surgeon, for instance, 
described how he would operate on a slight spinal curve if a child were very 
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distressed, but he would leave a more severe curve if it was safe to do so and 
the child did not appear to be concerned. The healthcare team may have to 
test and stretch their own abilities to inform, and involve, and thereby increase 
the competence of their patients. Along with respect for children’s views and 
values, there needs to be realism about the limits of clinical knowledge, skill 
and ‘factual’ understanding, and of the daunting risks and uncertainties in 
some healthcare treatment and research.  
 
 
Risks in healthcare research 
 
Consent involves evaluating risks and considering whether to undertake them. 
There are extra risks in research with children. They tend to be more vulnerable 
than adults to being damaged in the short or long term by interventions. They 
are liable to live with the effects for many extra years. They are generally less 
able to question, challenge, resist or refuse researchers’ proposals. Children’s 
actual or ascribed incompetence and dependence make them vulnerable to 
adults’ decision-making and control. While parents’ usual priority is to protect 
their child, they may unduly perceive the research intervention to be a 
protection against the greater dangers of the health problem being researched. 
There have been marvellous advances in the cancer treatments for children 
since the 1960s. Yet these partly relied on denying the need to ask for consent 
to healthcare research (see above, MRC, 1964). With cancer treatment trials, 
parents had no acknowledged rights to be informed or even to see their child; 
visiting might be allowed for one hour a week (Platt, 1959). The very great 
benefits of this research were gained at the cost of children being unable to 
refuse or to withdraw from painful and sometimes lethal research. Currently, 
children’s cancer treatment is almost all provided through clinical trials so that 
routinely consent to treatment entails consent to research. Yet this can set child 
cancer patients’ future collective interests over their present individual interests, 
considering that experimental treatments are as likely to be inferior as superior 
to standard treatments (Children’s Oncology Group, 2005:1295). Parents may 
enter their child for treatment trials so gruelling that, as some adults admit, they 
would refuse to enter the trials themselves. Belief in redemptive childhood that 
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promises better, brighter futures for families and for humanity generally may 
also subliminally encourage adults to invest extra hope and enthusiasm in 
research with sick or disabled or disturbed children. In these ways, children can 
lose the primary protections against research risks: the freedom to give or 
withhold consent, to withdraw at any time, and so to resist coercion. This next 
section reviews some confusions about risk which can increase children’s 
vulnerability.  
 
 
Calculating risk 
 
Risk is frequently discussed as if it is wholly quantifiable, but this view notices 
only one dimension of risk: calculating its frequency or likelihood of occurring. If 
seven out of 100 people develop severe adverse reactions to a drug, the risk of 
‘severe side effects’ is seven per cent. The word ‘severe’ introduces the other 
vital dimension of risk: its magnitude or intensity, the contested qualitative 
aspect of risk. Consensus on what counts as ‘severe’ or ‘minimal’ is often 
elusive and one person’s ‘severe’ might be another person’s ‘slight’. This 
uncertainty about intensity in turn affects the supposedly reliable ‘objective’ 
measures of frequency when they involve categories of severity. Regular 
debates in medical journals record that many doctors regard collecting blood 
samples to be of ‘minimal’ risk, whereas many children fear needles as 
‘severely’ painful and invasive.  
  Possibly still more uncertain are the means of assessing the risks of intrusion, 
humiliation, embarrassment, misreport and misrepresentation, posed when 
questioning children (or any group). Health research ethics tends to identify risk 
with the central stage of projects - data collection and direct contact with 
research subjects. Yet the earlier and later stages of projects, from the choice 
of research questions and methods, to eventual dissemination and 
implementation of research findings, may also pose serious and far-reaching 
risks and harms (Alderson and Morrow, 2004). Research reports may 
deliberately or inadvertently propagate more widespread harms. They may 
further stigmatise disadvantaged groups, such as children with mental health 
and behaviour problems. When researchers package ghostly childhoods from 
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the British 1958 and 1970 longitudinal cohorts, they may promote conclusions 
and recommendations to influence policies on the supposed needs of today’s 
childhood, which do not take sufficient account of today’s very different 
circumstances and problems. Among the micro studies of small groups of 
children and macro surveys of large groups, attention is seldom paid to larger 
economic and political pressures and effects. For example, current ‘research-
based’ government policies are establishing schools that open for 50 hours a 
week and 48 weeks a year to contain children aged from early months to 14 
years (ECM 2003). Research has not yet addressed the potential effects and 
risks of such confinement, relating to the health of children and of society.  
   
 
‘Therapeutic research’ 
 
Further confusion arises, when calculating risk, from the blurring of risks with 
benefits, and research with treatment. Despite reservations about the term 
`therapeutic research', an early ethics report used the term to mean `research 
consisting in an activity which has also a therapeutic intention as well as a 
research intention towards the subjects' (US, 1977:33). The report expanded 
the types of permissible research on children, and described risks 
euphemistically as `minimal', `minor increase over minimal' and `greater than 
minor increase over minimal' - meaning the most serious risks of injury or 
death. The report warned that restrictions on research might leave children as 
`therapeutic orphans', suffering diseases for which no treatment could be 
developed, a warning recently promoted with greater international emphasis 
(ABPI, 2004:9).  
  ‘Non-therapeutic research’ is seen as including much healthcare and all social 
research not associated with a clinical treatment, including research about 
children’s views and experiences, their growth and the range of ‘normality’. This 
work is vital if children are to be protected from being over-diagnosed and over-
treated when they have physical and psychological states that are well within 
the ‘normal’ healthy range. ‘Non-therapeutic research’ has gradually gained 
ethics support, coming to be accepted as not illegal (BPA, 1980:1) and later as 
not necessarily ‘against the child’s interests’, even if it is not in the ‘best 
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interests’ of the child to be enrolled in research (Nicholson, 1986:234). The 
concept of ‘therapeutic research’ can skew risk assessments when highly risky 
research, such as toxic drug trials, is approved as ‘therapeutic’, but 
questionnaires with children about their healthcare needs and services are 
rejected as  ‘non-therapeutic’.      
  Risk is a relative concept. When a new treatment is tried on a ‘healthy 
volunteer’ (this term implies that patients in research are not also volunteers) in 
‘non-therapeutic research’ the level of risk must be very low. High risk 
treatments are accepted if they offer a slight hope to a dying child (US, 1977; 
BPA, 1980:1), although arguably a strong healthy person is better able to 
withstand the risk. The equation that the hoped-for benefit should always 
outweigh the degree of risk can permit taking the highest risks with most 
vulnerable children in greatest need, when extreme illness, disturbance, or fear 
of death force parents and practitioners to `try anything'. The equation can 
misleading imply that harm and benefit are measurable and comparable.  
  In confusions between therapy and research, `therapy’ implies the promise 
of effective treatment that does more good than harm, although the usual 
purpose of research is to test these hopes. It would therefore be more 
scientific and ethical to replace talk of `therapy’ and `therapeutic research’ 
with the more neutral accurate terms `treatment’, ‘test’ or `intervention’, for the 
following reasons. Treatment and research differ in their nature, purpose, 
methods and knowledge base, as shown in table 1, and informed consent 
depends on these differences being clearly explained. To blur treatment with 
research can increase ethical dilemmas, when talk of `therapeutic research’ 
(the term is not used in Helsinki 2000) and of `the child’s best interests being 
to take part in research’ imply that research can directly benefit research 
subjects. The treatment being tested might directly benefit them, but if 
research is systematic investigation then research itself cannot be 
‘therapeutic’, unless the subsequent findings are eventually published and 
implemented to benefit future patients. However, parents may feel that it is 
unethical or impossible to refuse or to withdraw their child from a research 
programme labelled ‘therapeutic’, for fear of harming the child. Clinical staff in 
research teams often have little understanding of equipoise (Alderson et al., 
1994), meaning honest uncertainty about the relative benefits of different 
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treatment arms in a trial. If the staff confuse research and experimental 
treatments with assured therapy they are even less able to inform potential 
participants accurately. Adults may believe that a child must be in a trial in 
order to obtain effective treatment. But if the treatment is only available within 
a research programme, its relative efficacy and the balance of harms and 
benefits will be uncertain. These uncertainties and risks have to be explained 
clearly if consent is to be informed. It is therefore preferable to avoid the terms 
‘therapeutic’ or ‘non-therapeutic’ research.      
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Table 1. Differences between healthcare treatment and research 
 
 Treatment Research  
Definition Diagnostic, preventative, 
palliative or curative 
intervention 
Systematic 
investigation 
Purpose, hoped for 
outcomes 
To improve the individual’s 
health status now 
To acquire 
knowledge that might 
benefit future patient 
groups 
Methods Conduct diagnostic tests, 
provide and advise on 
treatments and assess their 
effects   
Design protocols, 
collect, collate and 
analyse data, 
report findings  
Knowledge base for 
treatment decisions  
`Best’ option, as far as can 
be known, for each patient 
`pragmatic certainty’ 
Randomization or 
other allocation 
method to fit 
protocol.   
Equipoise.   
 
 
Elusive risks 
 
Consent may be being stretched into performing functions that it cannot 
adequately cover in new forms of treatment and research. Consent is 
premissed on a one-to-one patient-practitioner or participant-researcher dyad, 
whereas large treatment or research teams may be involved. This 
complicates the coherence, consistency and continuity of information, of 
confidentiality, and of agreed working methods and relationships as, for 
example, we observed in our neonatal study. Does consent agreed with one 
practitioner signify consent to the entire team? How can the whole team keep 
up to date with rapidly changing plans for each baby? Should all the staff have 
access to every child’s personal information? Yet consent to treatment does 
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at least tend to be time and space limited: a specific event on a selected body. 
Even if the treatment course or its effects last a lifetime these will end with 
death, whereas consent to research can involve unknown and boundless 
potential.  
  In the new medical technologies, data are distributed across global space in 
telemedicine, and across time through ‘immortal’ stem cell-lines. Databanks of 
DNA or of children’s personal details in longitudinal studies are hired out to 
numerous research teams, and although ethics committees may vet the 
ostensible purposes of each research project, no one can predict all the 
possible uses and outcomes. Children have fewer rights than adults. 
Although, for example, parents may withhold their child’s data from the 
Icelandic genebank, if they do not, the children themselves cannot withdraw 
until they are 18, and they cannot withdraw their data retrospectively (Rose, 
2001). Brown and Webster (2004) considered the novel institutional, legal and 
economic networks and markets, and the future technologies of social control, 
surveillance, informatics, genetics, biomedical engineering, new hybrids and 
warfare that databanks may serve through as yet unknown technical and 
social processes. Consent’s supposedly direct link between the gift of 
research data (‘data’ meaning given) and the donor’s intellectual and moral 
prospective control over the specific use of data is dispersing elusively across 
this timeless diffusion. Risky new and growing challenges of healthcare 
research affect all age groups but children are doubly vulnerable in their 
present dependence and their likely longer lifespan over many future 
decades.     
 
 
Discussion: reflections on children’s consent 
 
(Practitioners and researchers will be referred to as professionals.) This final 
section suggests that main themes in this paper relate to professionals’ own 
reflexive understanding and also illustrate how professionals’ and children’s 
status and competencies can reflect and either mutually reinforce or 
undermine one another. Children’s consent, as with vulnerable people of all 
ages such as those with learning or mental health difficulties, prisoners or 
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asylum seekers, can raise extra ethical dilemmas. There are the risks of 
protecting children to the extent of silencing and excluding them from 
research so that their voices are not heard or are misunderstood, versus the 
risks of coercing or exploiting their involvement. Research and clinical 
governance encourage professionals to protect themselves and to be more 
cautious about risk taking, and this may affect how they involve children in 
their work. The more professionals are constrained by time, costs, protocols 
and regulations, useful though these may be in safeguarding standards, the 
fewer options professionals may be able to offer to the children they work 
with.  
  Children’s competence and autonomy mainly develop through direct social 
personal experience and not through age and physical growth. Some of the 
youngest children can be among the most informed and confident. The 
UNCRC (1989, article 12) endorses children’s involvement in sharing 
information and influencing decision-making and, in theory at least, English 
law respects competent children as decision makers. However, professionals’ 
care, information, support and respect for children can affect the levels of a 
child’s competence and autonomy, which rise and fall, partly depending on 
the adults’ beliefs about whether it is reasonable or wise to inform and involve 
the child in decision-making.  
  Professionals may simply test children’s apparently limited abilities and initial 
level of knowledge, or alternatively professionals may negotiate with children 
how far they can, and might be able to, understand with extra help. The adults 
need to be highly informed themselves about the research or treatment, and 
this process can test adults’ own abilities to communicate with children.       
  Consent involves concepts of competence, respect, dignity, informed choice 
and understanding, which can be harder to define and assess in their positive 
forms than in their negative absence in obvious incompetence, disrespect, 
violation, exploitation and abuse, misinformation, deceit, coercion or 
misunderstanding. Professionals who aim to respect children therefore tend at 
first to have to risk taking children’s competence partly on trust. Similarly, 
children initially have to trust that the adults will respect and not exploit or 
abuse them, until they can be reassured later by experiencing high standards 
of healthcare or research. Children with long-term conditions are frequently 
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involved in treatment and research and are also likely to have experienced 
limits and failures of healthcare, so that their consent may be highly informed.   
   Respect for consent involves protecting the child’s integrity of body, mind, 
personal information and reputation from unwanted invasion or intrusion when 
data are collected and later disseminated. Professionals may have to move 
beyond assumptions that their work is wholly benign and ‘therapeutic’ if they 
are to appreciate children’s own estimations of risks, costs, ‘side-effects’ or 
inconveniences.  
  Properly conducted, the consent process also protects professionals from 
criticisms, complaints and litigation. However, all concerned increasingly need 
to realise and question the limitations of traditional consent to cover work 
conducted by large teams, future contractors, and for future unknown 
purposes.   
  Consent is a paradox, often combining Kantian notions of the autonomous 
wise agent who alone can make the correct personal decision, with the 
courage to make and stand by a best guess about uncertain futures. The 
protective courage, implied in Linda’s cheerful tone when she spoke to her 
mother and her more sombre anxious tone talking to me after her mother left, 
was repeatedly shown by children in the surgery study. Adults make mistakes 
and children may be able to make wise choices besides having unique and 
essential embodied knowledge, which adults need to understand if the 
decisions they make for and with children are to be informed. Orthopaedic 
surgery, for example, aims to relieve pain, immobility or deformity, about 
which the child who lives in and is the body in question knows most.   
  A crucial part of consent is voluntariness. It is possible that the more 
professionals feel able to make informed, willing commitments to their work, 
the more they are able, willing, confident and, in the chaplain’s words earlier, 
‘big enough’ to share information and risks, options and commitments with 
children, instead of trying to impose these on children.    
  Basic principles for consent to healthcare and research with children need to 
be more clearly agreed, and analysed into their many component practical 
questions for professionals to address. Ways of informing and consulting with 
children, respecting their autonomy and their vulnerability need to be refined, to 
help to fulfil the longstanding guidance that `research involving children is 
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important for the benefit of all children and should be supported and 
encouraged, and conducted in an ethical manner' (BPA, 1980:1; RCPCH, 
2000:117). 
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